I am dumbfounded at those who don't acknowledge the success and potential of this opportunity.
Via research and studies, GSCG will put more patents out there, increase their global footprint by 4-5 clinics per year, and think about share price when they stumble on a cure for something.
The US is a decade behind in this medical field and LAHO beat everyone to the punch on that deal. Plain and simple.
[color=red][/color]All posts in the OTC are opinion and speculation based on individual DD..don't get personal.